Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Corti

Showing results (61-70 of 202) with videos related to

Pageof 21
Sort By:
Nature Medicine|January 20, 2022
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodiesLaura A VanBlargan, John M Errico, Peter J Halfmann, et al.
Antimicrobial Agents and Chemotherapy|January 26, 2026
Combination therapy with tobevibart and elebsiran potently reduces hepatitis B virus surface antigen levels in preclinical <i>in vivo</i> modelsJulia Noack, Yesseinia Anglero-Rodriguez, Jonathan Gall, et al.
Frontiers in Immunology|August 28, 2023
Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapyMaira Zorzan, Martina Castellan, Matteo Gasparotto, et al.
The American Journal of Pathology|October 11, 2008
CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infectionMario Cocco, Cristiana Bellan, Roxane Tussiwand, et al.
The Journal of Clinical Investigation|October 7, 2021
Exceptionally potent human monoclonal antibodies are effective for prophylaxis and treatment of tetanus in miceMarco Pirazzini, Alessandro Grinzato, Davide Corti, et al.
Nature Communications|February 1, 2020
Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoproteinJan Hellert, Julian Buchrieser, Florence Larrous, et al.
European Journal of Immunology|July 20, 2024
Site-specific serology unveils cross-reactive monoclonal antibodies targeting influenza A hemagglutinin epitopesPhilipp C G Paparoditis, Alexander Fruehwirth, Kajetana Bevc, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Broad receptor tropism and immunogenicity of a clade 3 sarbecovirusJimin Lee, Samantha K Zepeda, Young-Jun Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2008
Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in miceMichelle M Becker, Rachel L Graham, Eric F Donaldson, et al.
Frontiers in Immunology|August 20, 2021
Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV ChallengesSiqi Gong, Samir K Lakhashe, Dinesh Hariraju, et al.
Pageof 21

Showing results (61-70 of 202) with videos related to

Sort By:
Pageof 21
Nature Medicine|January 20, 2022
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodiesLaura A VanBlargan, John M Errico, Peter J Halfmann, et al.
Antimicrobial Agents and Chemotherapy|January 26, 2026
Combination therapy with tobevibart and elebsiran potently reduces hepatitis B virus surface antigen levels in preclinical <i>in vivo</i> modelsJulia Noack, Yesseinia Anglero-Rodriguez, Jonathan Gall, et al.
Frontiers in Immunology|August 28, 2023
Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapyMaira Zorzan, Martina Castellan, Matteo Gasparotto, et al.
The American Journal of Pathology|October 11, 2008
CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infectionMario Cocco, Cristiana Bellan, Roxane Tussiwand, et al.
The Journal of Clinical Investigation|October 7, 2021
Exceptionally potent human monoclonal antibodies are effective for prophylaxis and treatment of tetanus in miceMarco Pirazzini, Alessandro Grinzato, Davide Corti, et al.
Nature Communications|February 1, 2020
Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoproteinJan Hellert, Julian Buchrieser, Florence Larrous, et al.
European Journal of Immunology|July 20, 2024
Site-specific serology unveils cross-reactive monoclonal antibodies targeting influenza A hemagglutinin epitopesPhilipp C G Paparoditis, Alexander Fruehwirth, Kajetana Bevc, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Broad receptor tropism and immunogenicity of a clade 3 sarbecovirusJimin Lee, Samantha K Zepeda, Young-Jun Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2008
Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in miceMichelle M Becker, Rachel L Graham, Eric F Donaldson, et al.
Frontiers in Immunology|August 20, 2021
Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV ChallengesSiqi Gong, Samir K Lakhashe, Dinesh Hariraju, et al.
Pageof 21